Related Experiment Video

Updated: May 31, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL-driven

Corinna Albers1, Anna L Illert, Cornelius Miething

  • 1Department of Internal Medicine III, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

Blood
|July 1, 2011
PubMed

Insights

Researchers developed a novel retroviral vector for simultaneous oncogene expression and target gene knockdown in mouse models. This method efficiently identifies drug targets, like Raf1, in cancer research.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Genetic loss-of-function studies are crucial for understanding cancer development.
  • Limited availability of genetically modified mouse strains hinders these studies.
  • A need exists for efficient methods to study oncogene function and downstream targets.

Purpose of the Study:

  • To develop a versatile retroviral vector for simultaneous oncogene expression and target gene knockdown.
  • To validate the efficacy of this system in a murine model of chronic myeloid leukemia.
  • To identify specific molecular targets modulating oncogene-driven transformation.

Main Methods:

  • Designed a single retroviral vector expressing an oncogene and miR30-based shRNA for target knockdown.
  • Utilized a murine syngeneic bone marrow transplantation model for BCR-ABL-induced chronic myeloid leukemia.
  • Assessed oncogene expression and target knockdown efficiency in vitro and in vivo.

Main Results:

  • Demonstrated efficient oncogene expression and target knockdown in primary hematopoietic cells.
  • Confirmed the system's functionality in both in vitro and in vivo settings.
  • Identified Raf1, but not BRAF, as a modulator of BCR-ABL-dependent ERK activation and transformation.

Conclusions:

  • The developed retroviral expression system facilitates genetic loss-of-function studies in murine tumor models.
  • This system enables rapid validation of potential drug targets in various oncogene-driven cancers.
  • It overcomes limitations associated with traditional genetically modified mouse strains.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...